Underserved diseases in Africa
We prioritize diseases that are historically underserved, with a major emphasis on cancer—where delays and access barriers can be devastating.
Cancer
Primary Focus
Ghana
Starting Point
"Access solutions now and clinical research capacity for better options tomorrow."
Why this focus?
Our prioritization reflects the urgent need to address critical healthcare gaps in the region.
Underserved Populations
Many diseases that are well-managed elsewhere remain significantly underserved in Africa.
Access Delays Cost Lives
When cancer is involved, time is not neutral. Delays in access can mean the difference between life and death.
Research Capacity Gap
Building clinical research infrastructure brings better options to patients over time.
Our disease focus areas
As capabilities grow, we expand our support to include additional high-burden disease areas.
Solid Tumors
Comprehensive support for patients with solid tumor malignancies including lung, breast, gastrointestinal, and gynecologic cancers.
Hematologic Malignancies
Access pathway support for blood cancers where appropriate infrastructure and expertise exist in the local healthcare ecosystem.
High-Burden Diseases
Other under-resourced disease areas as our partnerships and infrastructure capabilities expand across the region.
Work with us in these focus areas
Whether you're a clinician treating these conditions or a sponsor developing therapies for these indications.